![François Chatelain](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
François Chatelain
Profile
François Chatelain founded CYTOO SA in 2008, where he worked as Co-Chief Executive Officer from 2009 to 2012.
Mr. Chatelain also formerly worked at Protogene Laboratories, Inc., as Director-Research & Development, Life Technologies, Inc., as Technology Manager, Genset Corp., as Principal from 1989 to 1993, and CEA LLP, as Principal.
Mr. Chatelain received his graduate degree from Université Paris 8 Vincennes Saint-Denis.
Former positions of François Chatelain
Companies | Position | End |
---|---|---|
Genset Corp.
![]() Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Corporate Officer/Principal | 31/12/1992 |
Life Technologies, Inc.
![]() Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Chief Tech/Sci/R&D Officer | - |
CEA LLP
![]() CEA LLP Miscellaneous Commercial ServicesCommercial Services CEA LLP operates as a CPA (certified public accountant) firm. It specializes in audit, banking, financing advisory, business consulting, valuation planning, due diligence, and financial forecast and projections. The company was founded by Robert Cairns in 1978 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | - |
Protogene Laboratories, Inc. | Chief Tech/Sci/R&D Officer | - |
CYTOO SA
![]() CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Chief Executive Officer | - |
Training of François Chatelain
Université Paris 8 Vincennes Saint-Denis | Graduate Degree |
Experiences
Positions held
Linked companies
Private companies | 5 |
---|---|
Life Technologies, Inc.
![]() Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Genset Corp.
![]() Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Health Technology |
CEA LLP
![]() CEA LLP Miscellaneous Commercial ServicesCommercial Services CEA LLP operates as a CPA (certified public accountant) firm. It specializes in audit, banking, financing advisory, business consulting, valuation planning, due diligence, and financial forecast and projections. The company was founded by Robert Cairns in 1978 and is headquartered in Carlsbad, CA. | Commercial Services |
Protogene Laboratories, Inc. | |
CYTOO SA
![]() CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Health Technology |
- Stock Market
- Insiders
- François Chatelain